2617 A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma. A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN)
| Autor: | Bergmann, L., Grünwald, V., Maute, L., Grimm, M.O., Weikert, S., Schleicher, J., Klotz, T., Greiner, J., Westermann, J., Hartmann, A., Moritz, B., Gauler, T. |
|---|---|
| Zdroj: | In European Journal of Cancer September 2015 51 Supplement 3:S517-S517 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect